TEMPO pilot

Limbic Inc.'s generative AI-enabled medical device Unpacked, which delivers CBT-based treatment via a voice agent for depression, is on the U.S. market under the FDA's TEMPO pilot, marking the first s…

On August 5, the U.S. Food and Drug Administration (FDA) named Cadence the second participant in its TEMPO pilot program for HypertensionOS, a software device that generates protocol-bound medication-…